Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-05-11Clinical Trial Update: Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies [Phase 2]
Phase 2 clinical trial update examining chemotherapy-related anemia in patients with non-myeloid malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2009-05-01Clinical Trial Update: Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment [Phase 2]
Phase 2 trial evaluating intravenous RPR109881 in advanced breast cancer patients refractory to anthracycline, taxane, and capecitabine has …
-
CLINICAL_TRIALS trial_result · 2009-05-01Clinical Trial Update: 3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer [Phase 3]
This update reports on a Phase 3 trial comparing three years of anastrozole versus no treatment as extended adjuvant therapy for postmenopau…
-
CLINICAL_TRIALS trial_result · 2009-05-01Clinical Trial Update: ATAC - Endometrial Sub-Protocol [Phase 3]
Phase 3 trial update for the ATAC study’s endometrial safety sub-protocol in breast cancer has completed as part of the overall ATAC program…
-
CLINICAL_TRIALS trial_result · 2009-05-01Clinical Trial Update: ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years [Phase 3]
A Phase 3 trial comparing ARIMIDEX (anastrozole) with Nolvadex (tamoxifen) in women with breast cancer who have been treated with tamoxifen …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-04-30FDA Approved: ARIMIDEX — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals, Inc.'s supplemental application for ARIMIDEX (anastrozole). This action typically updates labeling, in…
-
CLINICAL_TRIALS trial_result · 2009-04-30Clinical Trial Update: Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer [Phase 2]
Phase 2 clinical trial evaluating whole-body hyperthermia in combination with chemotherapy for metastatic breast, ovarian, endometrial, or c…
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors [Phase 1]
This is a Phase 1 dose-escalation trial of 2-Deoxy-D-glucose (2DG) in adults with advanced solid tumors, spanning multiple cancer types and …
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: ATAC - Bone Density Sub-Protocol [Phase 3]
Phase 3 ATAC trial's bone density sub-protocol has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study [Phase 2]
A Phase II neoadjuvant study in ER+/PgR+ breast cancer completed, evaluating Arimidex (anastrozole) with or without Iressa (gefitinib).
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Ph II Early BC Pre-Surgical Biologic Study [Phase 2]
Phase II study in breast cancer evaluating an early pre-surgical biologic approach has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of Iressa (gefitinib) and Faslodex (fulvestrant) in patients with advanced or metastatic…
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 study evaluating ZD1839 (Iressa) in combination with docetaxel as first-line therapy for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: IRESSA™ (Gefitinib) in Breast Cancer Patients [Phase 2]
This update reports on a Phase 2 trial of gefitinib (IRESSA) in breast cancer patients that has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: Quality Of Life While Receiving Faslodex
A completed clinical trial update reporting on quality of life for patients with breast cancer receiving Faslodex (fulvestrant).
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients
Observations from the regular use of Faslodex (fulvestrant) in patients with advanced breast cancer from a terminated clinical trial.
-
CLINICAL_TRIALS trial_result · 2009-04-10Clinical Trial Update: Second Line Breast Cancer Trial [Phase 3]
Phase 3 trial in second-line advanced breast cancer sponsored by AstraZeneca has completed.
-
CLINICAL_TRIALS research · 2009-04-09Clinical Trial Update: Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects [Phase 2]
Phase 2 clinical trial update on androgen therapy for breast cancer patients experiencing aromatase inhibitor-induced side-effects, such as …
-
FDA approval · 2009-04-08FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Herceptin (trastuzumab) submitted by Genentech, Inc. This action updates the product's label…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer [Phase 1]
Phase 1 study evaluating motexafin gadolinium in combination with docetaxel for advanced cancers; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: 131-I-TM-601 Study in Adults With Solid Tumors [Phase 1]
Phase 1 update on the radiopharmaceutical 131I-TM-601 in adults with solid tumors, including breast cancer, non-small cell lung cancer, mela…
-
CLINICAL_TRIALS research · 2009-03-31Clinical Trial Update: Trial of Myocet in Metastatic Breast Cancer [Phase 3]
An update on a Phase 3 trial of Myocet in metastatic breast cancer; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort. [Phase 3]
Phase 3 trial evaluating Acupression's bracelets for nausea and vomiting induced by FEC100 chemotherapy in breast cancer has completed.
-
FDA approval · 2009-03-13FDA Approved: IXEMPRA — Supplemental Application (R-Pharm US Operating, LLC)
FDA has approved a supplemental application for IXEMPRA (ixabepilone) submitted by R-Pharm US Operating, LLC. This action approves an amendm…
-
CLINICAL_TRIALS research · 2009-03-13Clinical Trial Update: Markers for Breast Cancer
A completed National Cancer Institute-sponsored trial report focusing on biomarkers for breast cancer.